Showing results (521-530 of 1,155) with videos related to
Sort By:
Pageof 116
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group StudyHolly H Gallion, Virginia L Brunetto, Michael Cibull, et al.Gynecologic Oncology|August 6, 2000
Biomarker conservation in primary and metastatic epithelial ovarian cancerK S Tewari, A S Kyshtoobayeva, R S Mehta, et al.Antiviral Research|April 1, 1993
Murine cytomegalovirus-inhibitory effects of ImuVertR W Sidwell, D F Smee, R P Warren, et al.Surgical Endoscopy|November 3, 2011
Endoscopic bilateral adrenalectomy in patients with ectopic Cushing's syndromeWijnand J Alberda, Casper H J van Eijck, Richard A Feelders, et al.Journal of Cancer Therapy|October 29, 2013
Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus modelsLiesl K Jeffers, Kaiwen Duan, Lesley G Ellies, et al.Scientific Reports|February 15, 2024
Diversity of selected toll-like receptor genes in cheetahs (Acinonyx jubatus) and African leopards (Panthera pardus pardus)René Meißner, Prudent Mokgokong, Chantelle Pretorius, et al.Critical Reviews in Oncology/Hematology|January 27, 2015
Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an exampleU Rochau, B Jahn, V Qerimi, et al.Tomography (Ann Arbor, Mich.)|October 26, 2022
Prostate Cancer Biochemical Recurrence Resulted Negative on [<sup>68</sup>Ga]Ga-PSMA-11 but Positive on [<sup>18</sup>F]Fluoromethylcholine PET/CTRiccardo Laudicella, Flavia La Torre, Valerio Davì, et al.The International Journal of Cardiovascular Imaging|February 14, 2025
Is cardiopulmonary transit time (CPTT) measured by using dynamic rubidium cardiac PET/CT a predictor for cardiac function?Lena C Seige, Boya Zhang, Jakob Heimer, et al.Gynecologic Oncology|February 25, 2020
Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinomaDimitrios Nasioudis, Sruthi Sakamuri, Emily M Ko, et al.Pageof 116